Phosphorothioate-stimulated uptake of short interfering RNA by human cells

EMBO Reports

Volumn 6, Issue 12, 2005, Pages 1176-1181

  Overhoff, Marita ^a   Sczakiel, Georg ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Caveolin; Cellular uptake; Nonviral vector; siRNA, delivery; siRNA, transport

Indexed keywords

CAVEOLIN; LAMIN A; LAMIN C; MESSENGER RNA; OLIGONUCLEOTIDE; PHOSPHOROTHIOIC ACID; SMALL INTERFERING RNA;

ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; ENDOTHELIUM CELL; EXPOSURE; GENE VECTOR; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; UMBILICAL VEIN;

CAVEOLINS; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; LAMININ; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; OKADAIC ACID; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RNA, SMALL INTERFERING; UMBILICAL VEINS;

MAMMALIA;

EID: 28544444484     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400535     Document Type: Article

References (27)

1. Allen TM, Cullis PR (2004) Drug delivery systems: Entering the mainstream. Science 303: 1818-1822
2. Bachellerie JP, Cavaille J, Hüttenhofer A (2002) The expanding snoRNA world. Biochimie 84: 775-790
3. Beltinger C et al (1995) Binding uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest 95: 1814-1823
4. de Diesbach P et al (2000) Identification, purification and partial characterisation of an oligonucleotide receptor in membranes of HepG2 cells. Nucleic Acids Res 28: 868-874
5. Dorsett Y, Tuschl T (2004) siRNAs: Applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3: 318-329
6. Elbashir SM et al (2001a) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498
7. Elbashir SM, Lendeckel W, Tuschl T (2001b) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15: 188-200
8. Elbashir SM, Harborth J, Weber K, Tuschl T (2002) Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213
9. Fra AM, Williamson E, Simons K, Parton RG (1995) De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci USA 92: 8655-8659
10. Hannon GJ, Rossi JJ (2004) Unlocking the potential of the human genome with RNA interference. Nature 431: 371-378
11. Hartmann G, Krieg AM (2000) Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 164: 944-952
12. Kalota A, Shetzline SE, Gewirtz AM (2004) Progress in the development of nucleic acid therapeutics for cancer. Cancer Biol Ther 3: 4-12
13. Kretschmer-Kazemi Far R, Sczakiel G (2003) The activity of siRNA in mammalian cells is related to structural target accessibility: A comparison with antisense oligonucleotides. Nucleic Acids Res 31: 4417-4424
14. Krieg AM, Davis HL (2001) Enhancing vaccines with immune stimulatory CpG DNA. Curr Opin Mol Ther 3: 15-24
15. Laktionov PP et al (1999) Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes. Nucleic Acids Res 27: 2315-2324
16. Laktionov PP et al (2004) Cell-surface-bound nucleic acids: Free and cell-surface-bound nucleic acids in blood of healthy donors and breast cancer patients. Ann NY Acad Sci 1022: 221-227
17. Lehmann M, Sczakiel G (2005) Spontaneous uptake of biologically active recombinant DNA by mammalian cells via a selected double-stranded DNA segment. Gene Ther 12: 446-451
18. Lingor P, Michel U, Schöll U, Bähr M, Kügler S (2004) Transfection of 'naked' siRNA results in endosomal uptake and metabolic impairment in cultured neurons. Biochem Biophys Res Comm 315: 1126-1133
19. Menezes J, Leibold W, Klein G, Clements G (1975) Establishment and characterization of an Epstein-Barr virus (EBV)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-negative African Burkitt's lymphoma. Biomedicine 22: 276-284
20. Overhoff M, Wünsche W, Sczakiel G (2004) Quantitative detection of siRNA and single-stranded oligonucleotides: Relationship between uptake and biological activity of siRNA. Nucleic Acids Res 32: E170
21. Parton RG, Richards AA (2003) Lipid rafts and caveolae as portals for endocytosis: New insight and common mechanisms. Traffic 4: 724-738
22. Pelkmans L, Burli T, Zerial M, Helenius A (2004) Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 118: 767-780
23. Scanlon KJ (ed). (1998) Therapeutic Applications of Ribozymes. Totowa, NJ, USA: Human Press Inc.
24. Schneider U, Schwenk HU, Bornkamm G (1977) Characterization of EBV-genome negative 'null' and 'T' cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 22: 204-213
25. Soutschek J et al (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432: 173-178
26. Toulmé JJ, Di Primo C, Boucard D (2004) Regulating eukaryotic gene expression with aptamers. FEBS Lett 567: 55-62
27. Wadhwa R, Kaul SC, Miyagishi M, Taira K (2004) Vectors for RNA interference. Curr Opin Mol Ther 6: 367-372